Clinical Trial Update: Testing P2Y12 Platelet Inhibitors Generics Beyond Bioequivalence [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating generics of P2Y12 platelet inhibitors beyond bioequivalence for cardiovascular diseases including acute coronary synd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Syndrome

Snippet

Sponsor: Cairo University | Conditions: Cardiovascular Diseases, Acute Coronary Syndrome | Phase 3 | Status: COMPLETED